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The objective of this study was to estimate the prevalence of different serological markers of hepatitis 
A, B and C viruses and Treponema pallidum among the adult population of Argentina. to achieve this, 
adults who attended health services for premarital exams (which are mandatory and includes screening 
for syphilis) were recruited. A cross-sectional study was designed with a cluster sampling strategy. 
Couples who attended selected health services for premarital screening between 2013 and 2014 in 
Buenos Aires, Cordoba, Mendoza and Santa Fe provinces were included. A total of 3833 individuals were 
recruited. Anti-HAV prevalence was 63.9%, anti-HCV 0.3%, anti-HBc (without HBsAg) 1.9%, HBsAg 
0.3%, and T pallidum 0.8%. Anti-HAV was higher among older participants, foreigners and those from 
the lower strata. HBV increased with age and was higher among foreigners and those with lower formal 
educational level. Anti-HCV frequency increased with age. premarital screening of viral hepatitis could 
constitute an instance of diagnosis, vaccination and inclusion in care of those in need. Results from this 
study will allow the national hepatitis programs to design public policies in order to diminish the impact 
of these infections on the population.
Viral hepatitis is a major public health problem that affects 400 million people worldwide and is responsible for 
1.4 million deaths per year including both, acute infection and hepatitis-related liver cancer and cirrhosis. Most 
of those deaths (95%) are attributable to hepatitis B and C. The five hepatitis viruses described (A, B, C, D and 
E) are very different; they are characterized by different transmission routes and probabilities, affecting diverse 
groups of the population, existing differential prophylaxis options and in consequence, resulting in distinct health 
outcomes1. Hepatitis A virus (HAV) and Hepatitis E virus (HEV) are both enterically transmitted acute infec-
tions. Viral infections occur mostly by person-to-person transmission and through consumption of contaminated 
water or food. Therefore, prevalence is strongly associated with socioeconomic development. Vaccination against 
HAV has effectively reduced the infection burden. Transmission of both, HAV and HEV, can be prevented by 
improving sanitation and access to safe water and food. Hepatitis B virus (HBV) and Hepatitis C virus (HCV) are 
transmitted through contact with infected blood or semen. More than 95% of adults with hepatitis B infection 
resolve it during the acute phase, however 95% of neonates and 20–30% of children between 1–5 years of age 
progress to chronic infection. The implementation of universal HBV vaccination has resulted in a decrease in 
prevalence in many parts of the world. As regards HCV, approximately 80% of acute hepatitis C cases progress to 
chronic infection, and 10–20% of these will develop chronic liver disease complications such as cirrhosis and/or 
hepatocellular carcinoma1,2.
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Viral hepatitis infections are mostly diagnosed by testing serological markers. The diagnosis of acute HAV 
infection is made by detecting the presence of anti-HAV IgM antibodies. For epidemiological issues, total 
anti-HAV antibodies (IgM and IgG) can also be tested. For HBV, the diagnosis testing should include several 
serological markers: HBsAg, anti-HBs, HBeAg, anti-HBe, and anti-HBc IgM and IgG. However, HBsAg is the 
serological hallmark of infection due to the fact that HBsAg can be detected within 1 to 10 weeks after infection, 
and persistence of this marker for more than 6 months suggests chronic infection. Previous HBV infection is 
usually detected by the presence of anti-HBc. HCV screening is performed by an antibody test, and when the 
anti-HCV antibody test is positive, current infection should be confirmed by HCV RNA test2.
The World Health Organization also estimates that only 1 in 20 individuals with hepatitis know their sta-
tus and that 1 in 100 of those infected are on treatment1. These epidemiological data clearly reveal the need to 
improve the tools and approaches currently available, like extended hepatitis A and B vaccination and hepatitis 
C treatment that can attain cure rates of over 90%. To achieve these objectives, WHO adopted a new strategy: the 
“Prevention and Control of Viral Hepatitis Infection: Framework for Global Action” aimed at eliminating viral 
hepatitis as one of the major public health threats by 2030.
In line with international strategies, a national program on viral hepatitis control was implemented in 
Argentina in 2012 (Programa Nacional de Control de las Hepatitis Virales, Dirección de SIDA y ETS (DSyETS), 
Ministerio de Salud y Desarrollo Social de la Nación). The main objectives of this program are to warrant pre-
vention, diagnosis and treatment of viral hepatitis in order to decrease the incidence of infections. Currently, 
Argentina has provided access to hepatitis A and B vaccines since 2005, for newborns/children since 2000, and 
for adults since 2012, respectively. However, due to their recent universal adoption, most adult populations are 
not immunized. Regarding hepatitis C, Argentina has been providing treatment to all patients regardless of liver 
fibrosis since December 2017. Epidemiological studies on viral hepatitis conducted in Argentina have mostly 
been focused on most at-risk groups. These studies revealed a high HBV prevalence among men who have sex 
with men (23–37%), male-to-female transgenders (40%), drug users (injecting, 42% and non-injecting, 9%), as 
well as female sex workers (14%). High prevalence of hepatitis C virus was also identified in the same groups (1.9–
7.5% among MSM, 4.5% among male-to-female transgenders, 54.6% among injecting drug users, 7.5% among 
non-injecting drug users, and 4.3% among female sex workers)3–7. However, no previous studies have investigated 
the prevalence of HCV among less exposed groups.
Syphilis is a sexually transmitted bacterial infection caused by Treponema pallidum subspecies pallidum (T. 
pallidum). Even when syphilis can be efficiently diagnosed and treated, it continues to be an important health 
problem. The global syphilis prevalence has been estimated at 0.5% (0.4–0.6%) and the regional values range from 
0.2% to 1.8% with the African Region having the highest incidence rate followed by the region of the Americas.8,9. 
The global prevalence of syphilis in Argentina is unknown, however, previous studies conducted by our group 
found a high prevalence among men who have sex with men (MSM) (20.5%), female sex workers (22.4%) and 
female transgender sex workers (50%)4,5,10.
The main goal of this study was to estimate the prevalence of different serological markers of hepatitis A, B 
and C viruses and Treponema pallidum among the adult population of Argentina. To achieve this objective, adults 
who attended health services aimed at premarital exams were studied. Premarital exam, which only includes 
screening for syphilis, is mandatory and free of charge in Argentina. The study population included male and 
female adult individuals from all socioeconomic and sociocultural strata.
Methods
study population. We conducted a cross-sectional study using a cluster sampling strategy. Adult individuals 
who attended health services for premarital exams (which includes screening for syphilis) were included in the 
study. Recruitment was performed in Buenos Aires, Greater Cordoba, Río Cuarto, Greater Mendoza, Greater 
Santa Fe, and Rosario from September 2013 to October 2014.
ethics statement. International and national ethical guidelines for biomedical research involving human 
subjects were followed. This research study was approved by a local Institutional Review Board (IRB) (Comité 
Independiente de Etica en Investigación, Nexo AC Buenos Aires, Argentina), and conducted in compliance with 
all federal regulations governing the protection of human subjects. All potential participants signed a written 
informed consent prior to entering the study.
sampling methodology. Sampling places were selected through cluster sampling considering places with 
more than 5000 marriages per year according to the last census (2010). Then, we considered the logistic possi-
bilities in each city. Finally, the following provinces, cities and hospitals were selected for sampling: Buenos Aires 
province: Melchor Romero (Hospital Interzonal de Agudos y Crónicos Dr. Alejandro Korn), La Plata (Hospital 
Interzonal Especializado de Agudos y Crónicos San Juan de Dios, and Hospital Interzonal General de Agudos, 
General San Martín), Lanus (Hospital Interzonal General de Agudos Evita), and Florencio Varela (Hospital Zonal 
General de Agudos Mi Pueblo); Córdoba Province: Córdoba City (Hospital Rawson, and Centro Municipal de 
la Ciudad de Córdoba), and Rio Cuarto (Centro Municipal de la Ciudad de Río Cuarto); Mendoza Province: 
Mendoza City (Hospital Central and Centro de Salud N°2), and Guaymallén (Centro de Salud N°16); and Santa 
Fe Province: Santa Fe City (Hospital Dr. José María Cullen), and Rosario (Hospital Provincial, and Centro de 
Especialidades Médicas Ambulatorias de Rosario (CEMAR)).
sample collection and diagnosis of viral hepatitis and treponema pallidum. Anticoagulated 
blood was collected for the determination of viral hepatitis A, B and C as well as T pallidum infection. Diagnosis 
of T pallidum infection was conducted using quantitative VDRL (VDRL, Wiener Laboratorios, SAIC, Rosario, 
Argentina). Markers of hepatitis A, B and C infection were determined using ELISA (BIOELISA HAV 96 TESTS, 
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BIOELISA HBsAg 3.0 96 TESTS, BIOELISA ANTI-HBC 96 TESTS, and BIOELISA HCV 4.0 96 TESTS, Biokit, 
Werfen, Barcelona). Anti-HBc presence without HBsAg detection was considered as an indicative of a previous 
exposure to HBV, and HBsAg presence was considered as a marker of present infection.
All participants obtained their lab results during medical consultation and those who needed it were referred 
to local hospitals for medical care and treatment.
statistical analysis. All data were included in a database and analyzed using SPSS (IBM Corp. Released 
2013. IBM SPSS Statistics for Windows, Version 22.0. Armonk, NY: IBM Corp.). In all the analyses, the sample 
was weighted. Continuous variables were described using medians and interquartile ranges (IQRs), and categor-
ical data, using counts and percentages. For seroprevalences, ninety-five percent confidence intervals (95% CI) 
were estimated using exact binomial formula. Bivariate analyses were performed using Chi square test or Fisher’s 
exact test according to sample size. All p-values were two-sided and considered to be statistically significant when 
p < 0.05.
Results
Characteristics of the study group. A total of 3833 participants (1940 women, 50.6% and 1893 men, 
49.4%) were recruited between September 2013 and October 2014. Table 1 shows demographic characteristics 
of the participants classified by gender. Briefly, the median age of the participants was 30 years (IQR = 26–36, 
range = 18–84); most of them (94.2%) were born in Argentina and 68.3% completed high school level. In relation 
to their housing situation, 8.0% reported to live in precarious places, like shantytowns. A total of 76.6% individu-
als reported having a job position. However, only 76.4% of them make pension contributions. Regarding medical 
insurance, 66.5% of all the study population reported having it, either the job-based (55.0%) or pre-paid (11.5%). 
Considering all socioeconomic variables, samples were stratified into two strata: middle strata (66.6%) and lower 
strata (33.4%). No significant differences were observed between men and women except for employment status, 
pension contributions and health insurance, where a higher frequency was observed in men.
Men 
N = 1893% (n)
Women 
N = 1940% (n) p value
Province
Buenos Aires 38.5 (735) 38.3 (738)
0.994
Córdoba 20.0 (383) 19.9 (383)
Santa Fe 24.4 (466) 24.8 (477)
Mendoza 17.1 (327) 17.0 (327)
Age
Median, years (IQR) 30.0 (27–36) 30.0 (26–35.9)
0.561<30 years old 50.7 (968) 51.7 (994)
≥30 years old 49.3 (942) 48.3 (930)
Nationality
Argentinean 94.6 (1806) 93.9 (1807)
0.370
Foreigners 5.4 (104) 6.1 (118)
Housing situation
House/apartment 93.8 (1792) 93.1 (1792)
0.398
Poor housing 6.2 (119) 6.9 (133)
Formal educational Level
Completed high school 68.7 (1312) 68.8 (1325)
0.917
Incomplete high school 31.3 (599) 31.2 (600)
Employment
Yes 92.1 (1760) 59.6 (1148)
<0.001
No 7.9 (150) 40.4 (777)
Pension contributions (n = 2936)
Yes 78.2 (1377) 74.5 (855)
0.020
No 21.8 (383) 25.5 (293)
Health insurance
Yes 70.7 (1351) 61.1 (1177)
0.000
No 29.3 (560) 38.9 (748)
Strata
Middle 66.0 (1261) 65.3 (1257)
0.658
Lower 34.0 (649) 34.7 (667)
Table 1. Demographic characteristics of 3833 participants recruited in Argentina between September 2013 and 
October 2014.
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prevalence of viral hepatitis and t. pallidum. A total of 3833 participants were studied for anti-HAV, 
anti-HBc, HBsAg, anti-HCV and T pallidum infections. As per Table 2, anti-HAV prevalence was 63.9% (95%CI 
62.4–65.6), total anti-HBc 2.0% (95%CI 1.53–2.46), anti-HBc (without HBsAg) 1.91% (95%CI 1.47–2.35), HBsAg 
0.27% (95%CI 0.10–0.43), anti-HCV 0.26% (95%CI 0.10–0.43), and T pallidum 0.74% (95%CI 0.47–1.01). No 
significant differences were observed between men and women. No cases of anti-HBc/anti-HCV or HBsAg/
anti-HCV co-infection were identified in this cohort.
Viral hepatitis and T. pallidum prevalence were analyzed according to stratification among cities (Table 3). 
T. pallidum was significantly more frequent among participants from Buenos Aires (p = 0.008) and Santa Fe 
(p = 0.012) compared with Cordoba, and anti-HBc (without HBsAg) was significantly higher in Buenos Aires 
compared with other places (3.5%, p < 0.001).
Demographics and risk factor analysis. In relation to HAV, anti-HAV prevalence increased with age 
(p < 0.001). A higher frequency was also detected among foreigners (80.2% vs. 62.9%, p < 0.001) and those from 
the lower strata (80.5% vs. 55.2%, p < 0.001). The latter association reflects the higher frequency of anti-HAV 
observed among those living in precarious places (80.1% vs. 62.8%, p < 0.001), having lower formal educational 
level (80.3% vs. 56.5%, p < 0.001), without employment (74.3% vs. 60.6%, p < 0.001), without pension contribu-
tions (72.5% vs. 57.0%, p < 0.001), and without social security (78.2% vs. 56.5%, p < 0.001). With regard to HBV, 
Anti-HBc and/or HBsAg presence (indicative of previous exposure to the virus and present infection, respec-
tively) also increased with age (p < 0.001). Higher frequency of infection was also detected among foreigners 
(mostly from Peru, Paraguay and Bolivia) as compared to Argentineans (6.8% vs. 1.9%, p < 0.001) and those with 
lower formal educational levels (3.0% vs. 1.8%, p = 0.038). As well as anti-HAV and Anti-HBc and/or HBsAg, 
anti-HCV frequency increased with age (p = 0.007). However, no other variables were associated with infection. 
A significantly higher frequency of T. pallidum was found among those who had not completed high school com-
pared to those who had (1.3% vs. 0.5%, p = 0.017) (Table 4).
Discussion
Viral hepatitis infections are regarded as one of the main global health problems caused by five unrelated viruses, 
with HAV, HBV and HCV being of utmost epidemiological importance. Despite the fact that HAV and HBV vac-
cines have been available for many years and that there is strong evidence of a decrease in prevalence rates, these 
infections still constitute a health problem worldwide. In the case of HCV, new treatments based on direct-acting 
antivirals (DAAs) have revolutionized the cure of chronic HCV infection with rates above 90%. Even when vac-
cines and treatments are making progress on viral hepatitis eradication as a public health problem, there are still 
many challenges to face. The Global Health Sector Strategy (GHSS) on viral hepatitis 2016–2021 calls for the 
elimination of viral hepatitis as a public health threat by 2030 through the reduction of new infections by 90% and 
mortality by 65% compared with the 2015 baseline11.
In order to achieve these goals, a national program on viral hepatitis control was created in Argentina in 2012. 
In this context, this research study was designed to contribute to the information on the situation of viral hepatitis 
in the adult population. To obtain a representative sample of adults we decided to study individuals who attended 
public health services aimed at premarital exams (which includes screening for syphilis only by law). This strategy 
has been used in other countries in order to obtain more accurate epidemiological data regarding viral hepatitis 
Prevalence Total N = 3833% (n)
IgG anti-HAV 63.9 (2442)
IgG anti-HCV 0.3 (10)
Previous exposure to HBV HBsAg−anti-HBc+ 1.9 (71)
Acute or chronic HBV infection HBsAg+anti-HBc+/− 0.3 (10)
Treponema pallidum 0.8 (29)
Table 2. Prevalence of viral hepatitis and syphilis among 3833 participants recruited in Argentina from 
September 2013 to October 2014.
Prevalence
Total 
N = 3833% (n)
Buenos Aires 
N = 1457% (n)
Cordoba 
N = 765% (n)
Mendoza 
N = 650% (n)
Santa Fe 
N = 932% (n) p value
IgG anti-HAV 63.9 (2442) 65.3 (957) 62.9 (481) 64.4 (418) 62.4 (587) 0.193
IgG anti-HCV 0.3 (10) 0.1 (1) 0.5 (4) 0.3 (2) 0.3 (3) 0.271
Previous exposure to HBV (HBsAg−, anti-
HBc+) 1.9 (71) 3.5 (51) 0.5 (4) 1.4 (9) 0.7 (6) <0.001
Acute or chronic HBV infection (HBsAg+, 
anti-HBc+/−) 0.3 (10) 0.3 (5) 0.3 (2) 0.5 (3) 0.1 (1) 0.535
Previous exposure, acute or chronic HBV 
infection 2.2 (81) 3.7 (55) 0.9 (7) 1.8 (12) 0.9 (7) <0.001
Treponema pallidum 0.8 (29) 0.8 (12) 0.1 (1) 0.8 (5) 1.0 (9) 0.579
Table 3. Prevalence of viral hepatitis and syphilis among 3833 participants recruited in Argentina from 
September 2013 to October 2014. Stratification according to province.
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carrier rates in the general population12. The advantage of this population is that it comprises men and women 
with different educational levels and socio economic strata, due to the fact that in Argentina most individuals 
attend public hospitals for premarital examinations.
A single-dose hepatitis A virus vaccination was implemented in Argentina aimed at children of 12 months of 
age in 2005. After that, there was an abrupt decline in the incidence of HAV infection from 66.5 to 7.9/100.000, 
representing a decrease in 88.1%. A dramatic decline in fulminant hepatic failure (FHF) and liver transplan-
tation (LT) cases has also been observed13. Due to the fact that the HAV vaccine has been recently introduced 
only for children, we assume that the adults included in our study were mostly not vaccinated. Therefore, the 
antibodies detected in our cohort are commonly related to previous infections. In line with previous studies, a 
high anti-HAV prevalence rate (64%) was found, which was even higher among older participants and those with 
lower socioeconomic levels. The increase in prevalence with age was described previously and it was associated 
with the time of exposure to the virus as well as the fact that older individuals could have been exposed to worse 
sanitary conditions14. The high frequency found among those with low socioeconomic levels could probably be 
related to the ingestion of contaminated water and/or food. Previous studies clearly established that the lack of 
access to safe drinking water and sanitary facilities is related to the increase in anti-HAV prevalence rates. Several 
research studies performed in Argentina demonstrated the circulation of HAV in wastewater and river samples 
from different regions15,16. These results highlight the need to improve sanitation and the access to clean water, 
which along with mass vaccination will contribute to reducing viral circulation and infection17.
The latest available data on the prevalence of HBV and HCV in Argentina is based mainly on blood donors 
and specific at-risk groups3–7,18. Studies performed among blood donors revealed that HBV and HCV prevalence 
have significantly decreased over the past years. Considering a ten-year period (2004–2014), these prevalence 
rates decreased from 0.41 to 0.20% for HBsAg (p < 0.001), 2.31 to 1.38% for anti-HBc (p < 0.001) and 0.74 to 
0.39% for anti-HCV (p < 0.001). The decrease in prevalence rates could be attributed to several factors, like the 
implementation of voluntary/repeated donors instead of family/replacement donors (as the former have lower 
HAV %  
(p value)




T. pallidum % 
(p value)
Age
<30 years old 59.0 1.2 0.1 0.7
≥30 years old 69.2 3.1 0.5 1.1
(<0.001) (<0.001) (0.010) (0.221)
Nationality
Argentinean 62.9 1.9 0.3 0.8
Foreigners 80.2 6.8 0 1.8
(<0.001) (<0.001) (1.0) (0.121)
Housing situation
House/apartment 62.8 2.2 0.3 0.9
Poor housing 80.1 1.7 0 1.2
(<0.001) (0.817) (1.0) (0.487)
Formal educational Level
Completed high school 56.5 1.8 0.3 0.5
Incomplete high school 80.3 3.0 0.3 1.3
(<0.001) (0.038) (1.0) (0.017)
Employment
Yes 60.6 2.2 0.2 0.8
No 74.3 2.0 0.4 1.1
(<0.001) (0.793) (0.268) (0.415)
Pension contributions
Yes 57.0 2.2 0.3 0.9
No 72.5 2.5 0 0.4
(<0.001) (0.652) (0.347) (0.330)
Health insurance
Yes 56.5 2.1 0.2 0.8
No 78.2 2.4 0.3 1.2
(<0.001) (0.554) (0.743) (0.209)
Strata
Middle 55.2 1.9 0.3 0.7
Lower 80.5 2.7 0.2 1.2
(<0.001) (0.095) (1.0) (0.145)
Table 4. Demographics and risk factor analysis for viral hepatitis and syphilis of 3833 participants recruited in 
Argentina between September 2013 and October 2014.
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prevalence rates than the latter), the improved prevention methods used (e.g. HBV vaccination), changes in 
risk factors (e.g. a decline in injecting drug use), and the progress made in the specificity of screening tests18. 
In general, trends in blood donors provide an estimation of the trend in the general population, even when 
blood bank data may underestimate real prevalence rates. In fact, when comparing these prevalence data with 
the results obtained in our study population (both with similar age range; 18–84 in our study and 18–65 in blood 
banks), a higher frequency of anti-HBc in our cohort was found (1.9 vs. 1.38, p = 0.016). However, no significant 
differences were observed in HBsAg or anti-HCV prevalence rates. Regarding the risk factors associated with 
infection, the HBV prevalence rate was higher among older participants, foreigners and those with lower formal 
educational level. Increasing age has been extensively described as an independent factor associated with HBV 
exposure19. The higher frequency detected among foreigners could be attributed to the lower level of vaccine 
coverage in their original countries (mostly from Latin America). However, the scarce data on previous immuni-
zation (anti-HBs) prevents from making an assertion about it. This association, together with the high prevalence 
rates observed among those with lower formal educational level, was described several years ago among men who 
have sex with men and female sex workers3,7.
In relation to T. pallidum prevalence, this study reveals that syphilis was present in less than 1% of the group, 
with the prevalence reported in previous studies being higher among at-risk groups (22.4% among female sex 
workers, 20.5% among men who have sex with men, and 50.4% among female transgender sex workers)4,10,20,21. 
Data from the Ministry of Health reveals that syphilis has been increasing over the past five years in the coun-
try. The increase among pregnant women and congenital syphilis individuals is especially concerning. Among 
pregnant women, the prevalence increased from 2% in 2013 to 3.2% in 2017. The rate of the reported congenital 
syphilis has subsequently increased from 1 case per 100,000 live births in 2013 to 1.7/100,000 in 2017. Although 
the syphilis prevalence found in our specific population is low, national surveillance data highlight the need for 
targeted syphilis prevention strategies focused on young individuals22.
With respect to regional differences, in this study we observed a higher frequency of T. pallidum in Buenos 
Aires and Santa Fe, compared to Cordoba; and a higher frequency of previous exposure to HBV in Buenos Aires 
compared to other cities. These results are in line with previous data published by the Ministry of Health, where 
syphilis incidence has been increasing in several areas over the past five years, but particularly in Buenos Aires22. 
Even when no specific information is available on HBV prevalence in different cities of the country, one of the 
reasons for the higher frequency in Buenos Aires can be the fact that some groups of the population with high 
HBV prevalence, like men who have sex with men and female transgender, are most frequently concentrated in 
bigger cities, constituting thus a source of transmission for others.
This study was aimed to assess an adult population without specific risk factors and without the underestima-
tions that blood donors usually have. Our results demonstrate that even when prevalence rates of viral hepatitis 
were not alarming, premarital screening could constitute an instance of diagnosis, vaccination and inclusion in 
care for those in need. In fact, in some countries, this strategy has already been implemented or it is under con-
sideration23–26. This information will allow the national hepatitis programs to design public policies in order to 
diminish the impact of these infections on the population.
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